HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

danlou tablet

cardioprotective herbal preparation of Rhizoma chuanxiong, Rhizoma Alismatis, Rhizoma Curcumae Longae, Radix Paeoniae Rubra, Pericarpium trichosanthis, and Bulbus Allii macrostemi

Networked: 20 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        danlou tablet: 20
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - danlou tablet: 20

Experts

1.	Wang, Jie: 3 articles (12/2020 - 08/2012)
2.	Wang, Lei: 3 articles (08/2018 - 09/2015)
3.	Li, Lin: 2 articles (01/2022 - 12/2020)
4.	Chen, Jie: 2 articles (06/2016 - 01/2016)
5.	Mao, Wei: 2 articles (06/2016 - 01/2016)
6.	Miao, Jing: 2 articles (06/2016 - 01/2016)
7.	Xu, Xiao-ming: 2 articles (06/2016 - 01/2016)
8.	Mao, Shuai: 2 articles (01/2016 - 09/2015)
9.	Li, Guang-Xi: 1 article (06/2022)
10.	Liu, Zhi-Guo: 1 article (06/2022)

Related Diseases

1.	Acute Coronary Syndrome 09/01/2015 - "To demonstrate the hypothesis whether treatment with Danlou Tablet would improve clinical outcome in patients undergoing selective PCI with non-ST elevation acute coronary syndrome (NSTE-ACS) in China. " 01/01/2016 - "Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial." 09/01/2015 - "Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial." 02/20/2020 - "DanLou tablet (DLT), a famous traditional Chinese medicine prescription (TCMP) consisting of 10 herbal medicines, is extensively used for the treatment of angina pectoris and acute coronary syndrome in China. "
2.	Myocardial Ischemia (Ischemic Heart Diseases) 08/01/2018 - "To observe the in vivo effect of Danlou Tablet (, DLT) on myocardial ischemia and reperfusion (I/R) injury. " 08/01/2018 - "Protective Effects of Danlou Tablet () against Murine Myocardial Ischemia and Reperfusion Injury In Vivo." 01/01/2023 - "Danlou Tablet Protects Against Cardiac Remodeling and Dysfunction after Myocardial Ischemia/Reperfusion Injury through Activating AKT/FoxO3a Pathway." 01/01/2022 - "PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury." 12/05/2020 - "Danlou tablet inhibits the inflammatory reaction of high-fat diet-induced atherosclerosis in ApoE knockout mice with myocardial ischemia via the NF-κB signaling pathway."
3.	Reperfusion Injury 08/01/2018 - "Protective Effects of Danlou Tablet () against Murine Myocardial Ischemia and Reperfusion Injury In Vivo." 01/01/2023 - "Danlou Tablet Protects Against Cardiac Remodeling and Dysfunction after Myocardial Ischemia/Reperfusion Injury through Activating AKT/FoxO3a Pathway." 01/01/2022 - "PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury."
4.	Heart Diseases (Heart Disease) 03/01/2023 - "Danlou tablet (Dan) is reported to confer protective effects on several heart diseases. "
5.	Atherosclerosis 06/01/2016 - "[Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study]." 01/01/2021 - "Danlou Tablet Activates Autophagy of Vascular Adventitial Fibroblasts Through PI3K/Akt/mTOR to Protect Cells From Damage Caused by Atherosclerosis." 12/05/2020 - "Danlou tablet inhibits the inflammatory reaction of high-fat diet-induced atherosclerosis in ApoE knockout mice with myocardial ischemia via the NF-κB signaling pathway." 01/01/2016 - "[Effects of Xuefu Zhuyu Granule and Danlou Tablet on Anti-atherosclerosis Rats and Potential Mechanisms]." 01/01/2022 - "Danlou tablet (DLT), the traditional Chinese medicine has been commonly used for dyslipidemia, atherosclerosis, and coronary heart disease. "

Related Drugs and Biologics

1.	Apolipoproteins E (ApoE)
2.	Apolipoproteins
3.	Ethanol (Ethyl Alcohol)
4.	Lipids
5.	Nonprescription Drugs (Patent Medicines)
6.	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
7.	Interleukin-6 (Interleukin 6)
8.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9.	Messenger RNA (mRNA)
10.	Platelet-Derived Growth Factor

Related Therapies and Procedures

1.	Percutaneous Coronary Intervention
2.	Chinese Traditional Medicine (Traditional Chinese Medicine)